Back to search
FDAFDA · Food and drugs·Recall number D-0054-2016

Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-8060-29

Published October 28, 2015 · Recall initiated: September 29, 2015

Summary

FDA records drug Class III recall D-0054-2016, published October 28, 2015 and initiated September 29, 2015. Recalling firm: Hospira Inc.; Status: Ongoing; Reported quantity: 24,100 Syringes; Lot: Lot 34-531-DK, Exp 10/01/2015. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot 34-531-DK, Exp 10/01/2015
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-8060-29 recalled?

Yes. FDA published recall D-0054-2016 on October 28, 2015. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter